SUMMARY. We have examined the effects of ryanodine, an inhibitor of the release of sarcoplasmic reticulum calcium in cardiac muscle, on contractile tension and calcium-45 movement in aortic smooth muscle of guinea pigs to learn whether this agent also modifies the release of stored calcium in vascular smooth muscle. Ryanodine (3-100 /*M) suppressed the phasic contractions induced by caffeine and norepinephrine in calcium-free medium and prevented the stimulation of calcium-45 efflux by these agonists. Ryanodine did not significantly alter either the contractile response or the increased cellular influx of calcium-45 caused by high potassium in more than 1 mM calcium, suggesting that this agent does not affect depolarization-induced calcium entry into the cells. In a calcium-free, high potassium solution, the addition of calcium at concentrations of 1 mvi and less resulted in a contraction which appeared to depend largely on the release of calcium from intracellular stores. This contraction was blocked by ryanodine. These data are consistent with the hypothesis that ryanodine causes a diminished release of calcium from the intracellular store in vascular smooth muscle, as it does in cardiac muscle. Moreover, our results indicate that a calcium-induced calcium release may exist in smooth muscle, and that this release is antagonized by ryanodine. (Circ Res 58: 730-734, 1986) 
SUMMARY. We have examined the effects of ryanodine, an inhibitor of the release of sarcoplasmic reticulum calcium in cardiac muscle, on contractile tension and calcium-45 movement in aortic smooth muscle of guinea pigs to learn whether this agent also modifies the release of stored calcium in vascular smooth muscle. Ryanodine (3-100 /*M) suppressed the phasic contractions induced by caffeine and norepinephrine in calcium-free medium and prevented the stimulation of calcium-45 efflux by these agonists. Ryanodine did not significantly alter either the contractile response or the increased cellular influx of calcium-45 caused by high potassium in more than 1 mM calcium, suggesting that this agent does not affect depolarization-induced calcium entry into the cells. In a calcium-free, high potassium solution, the addition of calcium at concentrations of 1 mvi and less resulted in a contraction which appeared to depend largely on the release of calcium from intracellular stores. This contraction was blocked by ryanodine. These data are consistent with the hypothesis that ryanodine causes a diminished release of calcium from the intracellular store in vascular smooth muscle, as it does in cardiac muscle. Moreover, our results indicate that a calcium-induced calcium release may exist in smooth muscle, and that this release is antagonized by ryanodine. (Circ Res 58: 730-734, 1986) IT HAS been suggested that mobilization of calcium from intracellular stores, presumably sarcoplasmic reticulum (SR), in vascular smooth muscles, underlies the contractile effects of agents such as vasoactive amines and peptides 0ohansson and Somlyo, 1980) . Nevertheless, the role of the SR in regulating intracellular calcium concentration in vascular smooth muscle is not well understood, due to its low density and distribution in the cell, and to difficulties in isolating SR membranes from vascular smooth muscles. Pharmacological interventions which modify the release of intracellularly stored calcium have been used to investigate the contributions made by intracellularly stored calcium to smooth muscle contractions. These interventions include caffeine and local anesthetics, such as procaine (Endo, 1977; Itoh et al., 1981; Saida, 1982) . However, a limitation to the use of these agents is that both caffeine and procaine decrease the influx of calcium from the extracellular space (Jacobs and Keatinge, 1974; Leijten and Van Breemen, 1984; Spedding and Berg, 1985) . Therefore, it is difficult to differentiate the effect of these agents on the calcium release from that on the calcium influx when intact smooth muscle is used.
Ryanodine, a naturally occurring alkaloid, has been demonstrated to alter specifically calcium movements across SR membranes in cardiac and skeletal muscles (Jenden and Fairhurst, 1969; Sutko et al., 1979; Sutko and Willerson, 1980; Fabiato, 1985; Sutko et al., 1985) . Moreover, this agent alters the mechanical responses of certain smooth muscle preparations in a manner that suggests that it might produce similar effects in this tissue (Steinsland et al., 1973) . If ryanodine selectively modifies the function of the SR, it will be a powerfull tool for the study of the role of the SR in vascular smooth muscle contraction.
The present study was undertaken to learn how ryanodine modifies the release of calcium from intracellular stores in guinea pig aortic smooth muscle. The results suggest that this agent blocks the release of intracellularly stored calcium caused by norepinephrine (NE) and caffeine, but does not affect depolarization-dependent calcium entry from the extracellular space.
Methods
Aortas were isolated from 250-to 400-g male guinea pigs following a blow on the neck. For tension experiments, the helical strip of aorta was suspended in an organ bath filled with 10 ml Tyrode's solution containing (mM): NaCl, 136.8; KC1, 5.4; MgCl 2 , 0.5; NaHCO 3 , 11.9; and dextrose, 5.5; gassed with 95% O 2 and 5% CO 2 (pH 7.4; 37°C). High potassium solution was prepared either by hypertonically increasing KG to 60 mM or by isotonically substituting KC1 for NaCl. Norepinephrine (Sigma) and ryanodine (lot 704 RWP-1, S.P. Penick Corp.) were added to the Tyrode's solution from 1 mM stock solution, while caffeine (Nakarai Chemicals) was dissolved directly in the Ca flux experiments, the solutions were buffered with tris(hydroxymethyl)aminomethane (Tris) and gassed with 100% O 2 to avoid precipitation in the medium due to the presence of lanthanum. We had ensured, in preliminary experiments, that the results of tension experiments in Tris buffer were identical with those in a bicarbonate buffer. Uptake of 45 Ca by aortic muscles was measured by a cold lanthanum wash procedure (Karaki and Weiss, 1979) . First, the muscles were depleted of calcium by 20 minutes of exposure to 10 /*M NE in calcium-free medium, and then were transferred to calcium-free, potassiumdepolarizing solution containing KG, 142; MgCU, 0.5; dextrose, 5.5; 5 mM Tris (pH 7.4). Fifteen minutes later, 1 mM calcium containing Ca (2 jiCi/ml; total calcium was 2.5 mM). The muscles then were placed in a calcium-free medium, and the efflux of 45 Ca was initiated. The efflux medium was changed every 10 minutes. After 60-80 minutes, the muscles were exposed to 10 HM NE or 20 mM caffeine. The radioactivity in the efflux medium was counted in a liquid scintillation counter. Data are expressed as rate coefficient, which means the percent loss of 45 Ca content during each washing interval. Data represent the mean ± SEM. Differences were considered to be significant at the level of P < 0.05 when tested by Student's /-test.
Results
When 2.5 HIM calcium was present in the external medium, pretreatment of aortic muscles with 30 or 100 HM ryanodine did not significantly affect the rate of tension development and the peak amplitude of the contraction elicited by 60 mM potassium (n = 8 for each concentration). On the other hand, 30 JUM ryanodine slowed the development of responses to 1 fiM NE (the time for half-maximal response increased from 19 ± 3 seconds to 96 ± 17 seconds; P < 0.05) and decreased its peak tension by 22 ± 8% ( P < 0 . 0 5 ; H = 8).
In calcium-free solutions containing 0.5 mM EGTA, both caffeine (5-10 mM) and NE (1 I*M) induced an initial phasic contraction which, in the case of NE, was followed by a tonic one. Ryanodine selectively suppressed the phasic contraction due to both agents in a dose-dependent manner (Fig. 1) . The ryanodine-insensitive tonic contraction produced by NE was decreased by elevating the concentration of EGTA in the medium to 2 mM, supporting the view that this component was due to entry of superficially bound calcium or to the release of calcium from intracellular site which can be readily depleted by extracellular EGTA (Wheeler and Weiss, 1979; Weiss, 1980a, 1980b) . NE (10 IIM) and caffeine (20 mM) increased the 45 Ca efflux from aortic muscles into calcium-free medium, which effect is thought to result from an acceleration of release of stored calcium by these agents (Godfraind, 1976; Deth and Casteels, 1977; Casteels and Droogmans, 1981) . As shown in Figure  2 , the presence of 30 fiM ryanodine prevented this effect caused by NE. Similarly, ryanodine prevented the increase of 1 and 2 clearly indicate that ryanodine inhibits the release of calcium from the intracellular stores sensitive to NE or caffeine.
In the next series of experiments, we examined the effects of ryanodine on the contraction of aortic smooth muscle resulting from the reintroduction of calcium to muscles previously incubated in calciumfree, high potassium (140 mM) solution. Ryanodine (30 HM) significantly decreased the calcium-induced contraction of the muscles by 73 ± 6%, 57 ± 6%, and 42 ± 4% (n = 7) when the concentration of calcium added was 0.1, 0.3, and 1.0 mM, respectively. However, ryanodine did not significantly inhibit the contraction when the added calcium exceeded 2 mM. The suppression of this contraction could be due to inhibition by ryanodine of either calcium influx into the cell or of calcium-induced calcium release from the intracellular stores. To test these possibilities, we first examined the effect of ryanodine on the uptake of calcium by the muscles (Fig. 3) . After the muscles had been incubated in calcium-free, isotonic potassium solution for 20 minutes, 1 mM calcium with Ca uptake increased by high potassium. The results suggest that ryanodine does not affect depolarization-dependent calcium entry from the external medium. This hypothesis is consistent with the fact that ryanodine did not affect the contraction induced by 60 mM potassium in the presence of 2.5 mM calcium.
To assess the second possibility, we examined the dependency of the calcium-induced contraction on the extent of calcium loading of the intracellular store (Fig. 4) . In one group of muscles, the intracellular store was filled with calcium by exposing the muscles to a medium containing 60 mM KG and 2.5 mM calcium just before the introduction of calciumfree, high potassium solution. The ability of this procedure to load intracellular calcium stores was confirmed in separate experiments in which NEinduced phasic contractions obtained in calciumfree medium were shown to be augmented by this procedure. In a second group, the intracellular calcium store was depleted of calcium by three successive exposures to 1 HM NE in calcium-free buffer. Contractions that developed during the initial 5 minutes after the addition of 0.1 mM calcium were compared, since the calcium store might be significantly replenished after longer times. Figure 4 shows that both the rate of development and the amplitude of the contractions induced by 0.1 mM calcium were greater in the calcium-loaded than in the calciumdepleted muscles. Ryanodine suppressed the calcium-induced contraction developed for 5 minutes after exposure to calcium in the calcium-loaded muscles, but not in those that had been depleted of calcium. These results suggest that intracellularly stored calcium makes a significant contribution to the calcium-induced contraction elicited from depolarized muscles with intact calcium stores, and that a calcium-induced calcium release mechanism may be operable in this preparation. 
Discussion
The results obtained in this study suggest that ryanodine can diminish the release of calcium from intracellular stores in vascular smooth muscle without affecting the calcium influx from the extracellular space. The selective inhibition by ryanodine of only those contractions which involve the release of calcium from intracellular sites means that this agent has an advantage over caffeine or local anesthetics as a tool for the study of smooth muscle contraction. This selectivity also argues against an effect on subsequent steps in the smooth muscle contractile mechanism, such as myosin light chain kinase, which could be common to all of the agents tested. Although experimental verification is required, we are presently assuming from analogies with striated muscles that the SR is the intracellular calcium store affected by agents such as ryanodine and caffeine. This conclusion has been reached by other authors (Casteels and Droogmans, 1981; Itoh et al., 1982; Bond et al., 1984a Bond et al., , 1984b . Relatively high concentrations of ryanodine are required to affect vascular smooth muscle. This apparent insensitivity may be explained by the use-or depolarization-dependence exhibited by the actions of this agent on both skeletal and cardiac muscles (Sutko et al., 1985) , as well as by the actual characteristics of the ryanodine-binding site.
Calcium-induced contraction of depolarized muscles seemed to depend on calcium loading of the cells. However, we must consider an alternative possibility that this contraction might depend on superficially bound calcium. Since NE treatment, used to deplete calcium, can remove superficially bound calcium (Wheeler and Weiss, 1979; Weiss, 1980a, 1980b) , the different amounts of superficially bound calcium in two groups may explain the difference between the responses to 0.1 mM calcium if calcium at this site contributes to the calcium-induced contraction. As for this fraction of calcium, ryanodine does not seem to affect the mobilization of superficially bound calcium, since this agent did not inhibit the tonic contraction induced by NE in calcium-free medium. On the contrary, ryanodine greatly inhibited the contraction induced by calcium in calcium-loaded muscles. Therefore, we can conclude that calcium-induced contraction of depolarized muscle did not depend on superficially bound calcium, but on intracellularly stored calcium.
It has been suggested that calcium-induced calcium release underlies the caffeine-induced contraction in certain vascular smooth muscles (Itoh et al., 1981 (Itoh et al., ,1982 Saida and Van Breemen, 1984) . Caffeine is thought to increase the affinity of SR for calcium (Yamamoto and Kasai, 1982; Kirino et al., 1983) and to induce calcium release at physiological levels of free calcium in the cytoplasm even in the absence of calcium influx (Saida, 1982) . However, the release of calcium from intracellular stores by transmembrane calcium influx has not yet been demonstrated in vascular smooth muscle. Calcium-induced contraction in depolarized muscles has long been believed to be caused directly by transmembrane calcium influx. The present data indicate that this contraction is dependent on stored calcium rather than on calcium entry, especially when the external calcium is low. Since ryanodine does not inhibit calcium influx, inhibition of this contraction by ryanodine suggests that transmembrane calcium influx can trigger calcium release from intracellular stores in vascular smooth muscle as it does in cardiac muscles (Fabiato, 1983) .
The present findings suggest that ryanodine is a useful tool to assess a contribution of calcium release from intracellular stores to mechanical activity of vascular smooth muscle. Our results suggest that ryanodine inhibits SR calcium release in guinea pig aortic smooth muscle. Ryanodine can both increase and decrese the calcium permeability of cardiac and skeletal SR membranes, depending on the ryanodine concentration and experimental conditions used (Lattanzio and Sutko, unpublished observations; G. Meissner, personal communication). Consequently, the actual effects of ryanodine will have to be established for different experimental protocols and types of smooth muscles.
